Chemomab Therapeutics Ltd. Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-03-23: Form 20-F; Period of report 2025-12-31; Description 20-F; Document zk2634510.htm.
- 2025-04-04: Form 20-F; Period of report 2024-12-31; Description 20-F; Document zk2532902.htm.
- 2024-03-28: Form 20-F; Period of report 2023-12-31; Description 20-F; Document zk2431185.htm.
- 2019-03-25: Form 20-F; Period of report 2018-12-31; Description FORM 20-F; Document tv516701_20f.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-03-23 | 20-F | 2025-12-31 | 20-F | zk2634510.htm |
| 2025-04-04 | 20-F | 2024-12-31 | 20-F | zk2532902.htm |
| 2024-03-28 | 20-F | 2023-12-31 | 20-F | zk2431185.htm |
| 2019-03-25 | 20-F | 2018-12-31 | FORM 20-F | tv516701_20f.htm |
| 2013-04-23 | 20-F | 2012-12-31 | 20-F | zk1312988.htm |